More than 50% of all patients with colorectal cancer (CRC) develop liver metastases (CLM), a clinical condition characterized by poor prognosis and lack of reliable prognostic markers. Vδ1 cells are a subset of tissue-resident gamma delta (γδ) T lymphocytes endowed with a broad array of antitumor functions and showing a natural high tropism for the liver. However, little is known about their impact in the clinical outcomes of CLM.
Intrahepatic CD69+Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression / E. Bruni, M.M. Cimino, M. Donadon, R. Carriero, S. Terzoli, R. Piazza, S. Ravens, I. Prinz, V. Cazzetta, P. Marzano, P. Kunderfranco, C. Peano, C. Soldani, B. Franceschini, F.S. Colombo, C. Garlanda, A. Mantovani, G. Torzilli, J. Mikulak, D. Mavilio. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - 10:7(2022), pp. e004579.1-e004579.30. [10.1136/jitc-2022-004579]
Intrahepatic CD69+Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression
M.M. Cimino;M. Donadon;V. Cazzetta;P. Marzano;F.S. Colombo;A. Mantovani;G. Torzilli;J. MikulakPenultimo
;D. Mavilio
Ultimo
2022
Abstract
More than 50% of all patients with colorectal cancer (CRC) develop liver metastases (CLM), a clinical condition characterized by poor prognosis and lack of reliable prognostic markers. Vδ1 cells are a subset of tissue-resident gamma delta (γδ) T lymphocytes endowed with a broad array of antitumor functions and showing a natural high tropism for the liver. However, little is known about their impact in the clinical outcomes of CLM.
| File | Dimensione | Formato | |
|---|---|---|---|
|
D:Bruni E. et al. - JITC.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
6.45 MB
Formato
Adobe PDF
|
6.45 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
